Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax

被引:14
作者
Candoni, Anna [1 ]
Lazzarotto, Davide [2 ]
Papayannidis, Cristina [3 ]
Piccini, Matteo [4 ]
Nadali, Giampaolo [5 ]
Dargenio, Michelina [6 ]
Riva, Marta [7 ]
Fracchiolla, Nicola [8 ]
Mellillo, Lorella [9 ]
Dragonetti, Giulia [10 ]
Del Principe, Maria Ilaria [11 ]
Cattaneo, Chiara [12 ]
Stulle, Manuela [13 ]
Pasciolla, Crescenza [14 ]
De Marchi, Roberta [15 ]
Delia, Mario [16 ]
Tisi, Maria Chiara [17 ]
Bonuomo, Valentina [5 ]
Sciume, Mariarita [7 ]
Spadea, Antonio [18 ]
Sartor, Chiara [3 ]
Griguolo, Davide [13 ]
Buzzatti, Elisa [11 ]
Basilico, Claudia Maria [19 ]
Sarlo, Chiara [20 ]
Piccioni, Anna Lina [21 ]
Cerqui, Elisa [12 ]
Lessi, Federica [22 ]
Olivieri, Attilio [23 ]
Fanin, Renato [2 ]
Luppi, Mario [1 ]
Pagano, Livio [10 ]
机构
[1] Univ Modena & Reggio Emilia, Azienda Osped Univ Modena, Dept Med & Surg Sci, Sect Hematol, Modena, Italy
[2] Univ Udine, Div Hematol & Stem Cell Transplantat, ASUFC, Udine, Italy
[3] Univ Bologna, Inst Hematol & Med Oncol L&A Seragnoli, Bologna, Italy
[4] Azienda Osped Univ Careggi, Div Hematol, Florence, Italy
[5] Policlin GB Rossi, Div Hematol, AOUI, Verona, Italy
[6] Osped Vito Fazzi, Div Hematol, Lecc, Italy
[7] ASST Grande Osped Metropolitano, Dipartimento Ematol Oncol, Niguarda Canc Ctr, Milan, Italy
[8] Univ Milan, Fdn IRCCS CaGranda Osped Maggiore Policlin, UO Oncoematol, Milan, Italy
[9] Foggia & IRCCS Casa Sollievo Sofferenza, Div Hematol, San Giovanni Rotondo, Italy
[10] Univ Cattolica Sacro Cuore, Fdn Policlin A Gemelli IRCCS, Div Hematol, Polo Onco Ematol, Rome, Italy
[11] Fdn Policlin Tor Vergata, Hematol, Rome, Italy
[12] Spedali Civil Brescia, Sect Hematol, Brescia, Italy
[13] ASUGI, Div Hematol, Trieste, Italy
[14] IRCCS Ist Tumori Giovanni Paolo II, Haematol Unit, Bari, Italy
[15] IRCCS, Veneto Inst Oncol IOV, Dept Oncol, Onco Hematol, Padua, Italy
[16] Univ Bari, Hematol & Bone Marrow Transplantat Unit, Azienda Osped Univ Consorziale Policlin, Bari, Italy
[17] Univ Milan, San Bortolo Hosp Vicenza, Fdn IRCCS CaGranda Osped Maggiore Policlin, Cell Therapy & Hematol,7UO Oncoematol, Milan, Italy
[18] IRCCS Regina Elena Natl Canc Inst, Hematol & Stem Cell Transplant Unit, Rome, Italy
[19] Osped Circolo & Fdn Macchi, Div Hematol, ASST Sette Laghi, Varese, Italy
[20] Univ Campus Biomed, Hematol & Stem Cell Transplantat Unit, Rome, Italy
[21] Azienda Osped San Giovanni Addolorata, Dipartimento Ematol, Rome, Italy
[22] Azienda Osped Univ Padova, Dept Med, Hematol Unit, DIMED, Padua, Italy
[23] Azienda Osped Univ Osped Riuniti Ancona, Div Hematol, Ancona, Italy
关键词
D O I
10.1002/ajh.26846
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E80 / E83
页数:4
相关论文
共 6 条
[1]   Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents [J].
Aldoss, Ibrahim ;
Dadwal, Sanjeet ;
Zhang, Jianying ;
Tegtmeier, Bernard ;
Mei, Matthew ;
Arslan, Shukaib ;
Al Malki, Monzr M. ;
Salhotra, Amandeep ;
Ali, Haris ;
Aribi, Ahmed ;
Sandhu, Karamjeet ;
Khaled, Samer ;
Snyder, David ;
Nakamura, Ryotaro ;
Stein, Anthony S. ;
Forman, Stephen J. ;
Marcucci, Guido ;
Pullarkat, Vinod .
BLOOD ADVANCES, 2019, 3 (23) :4043-4049
[2]   Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia [J].
DiNardo, C. D. ;
Jonas, B. A. ;
Pullarkat, V. ;
Thirman, M. J. ;
Garcia, J. S. ;
Wei, A. H. ;
Konopleva, M. ;
Doehner, H. ;
Letai, A. ;
Fenaux, P. ;
Koller, E. ;
Havelange, V. ;
Leber, B. ;
Esteve, J. ;
Wang, J. ;
Pejsa, V. ;
Hajek, R. ;
Porkka, K. ;
Illes, A. ;
Lavie, D. ;
Lemoli, R. M. ;
Yamamoto, K. ;
Yoon, S. -S. ;
Jang, J. -H. ;
Yeh, S. -P. ;
Turgut, M. ;
Hong, W. -J. ;
Zhou, Y. ;
Potluri, J. ;
Pratz, K. W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07) :617-629
[3]   How I treat acute myeloid leukemia in the era of new drugs [J].
DiNardo, Courtney D. ;
Wei, Andrew H. .
BLOOD, 2020, 135 (02) :85-96
[4]   Infections of Venetoclax-Based Chemotherapy in Acute Myeloid Leukemia: Rationale for Proper Antimicrobial Prophylaxis [J].
Lee, Raeseok ;
Cho, Sung-Yeon ;
Lee, Dong-Gun ;
Choi, Hyeah ;
Park, Silvia ;
Cho, Byung-Sik ;
Kim, Yoo-Jin ;
Kim, Hee-Je .
CANCERS, 2021, 13 (24)
[5]   Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent [J].
On, Sandy ;
Rath, Carolyn G. ;
Lan, Michelle ;
Wu, Bobby ;
Lau, Kimberly M. ;
Cheung, Edna ;
Alegria, William ;
Young, Rebecca ;
Tan, Marisela ;
Kim, Carrie ;
Phun, Jennifer ;
Patel, Nimish ;
Mannis, Gabriel ;
Logan, Aaron C. ;
Kennedy, Vanessa ;
Goodman, Aaron ;
Taplitz, Randy A. ;
Young, Patricia A. ;
Wen, Raymond ;
Saunders, Ila M. .
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (01) :63-70
[6]   Acute Myeloid Leukemia, Version 2.2021 Featured Updates to the NCCN Guidelines [J].
Pollyea, Daniel A. ;
Bixby, Dale ;
Perl, Alexander ;
Bhatt, Vijaya Raj ;
Altman, Jessica K. ;
Appelbaum, Frederick R. ;
de Lima, Marcos ;
Fathi, Amir T. ;
Foran, James M. ;
Gojo, Ivana ;
Hall, Aric C. ;
Jacoby, Meagan ;
Lancet, Jeffrey ;
Mannis, Gabriel ;
Marcucci, Guido ;
Martin, Michael G. ;
Mims, Alice ;
Neff, Jadee ;
Nejati, Reza ;
Olin, Rebecca ;
Percival, Mary-Elizabeth ;
Prebet, Thomas ;
Przespolewski, Amanda ;
Rao, Dinesh ;
Ravandi-Kashani, Farhad ;
Shami, Paul J. ;
Stone, Richard M. ;
Strickland, Stephen A. ;
Sweet, Kendra ;
Vachhani, Pankit ;
Wieduwilt, Matthew ;
Gregory, Kristina M. ;
Ogba, Ndiya ;
Tallman, Martin S. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (01) :17-27